Note from the Editors
F. Augustovski,B. M. Yan and D. Greenberg. Note from the Editors. Value Health Reg Issues. 2013;2(2):10.1016/j.vhri.2013.05.006.
Note from the Editors Ver más »
F. Augustovski,B. M. Yan and D. Greenberg. Note from the Editors. Value Health Reg Issues. 2013;2(2):10.1016/j.vhri.2013.05.006.
Note from the Editors Ver más »
M. Jameleddine,H. Grati,M. C. Jebali,N. Harzallah,S. G. Marti,N. Soto,D. A. Pichon-Riviere and C. Hamouda. NEW TREATMENTS FOR MALIGNANT ADVANCED MELANOMA FOR ADULT PATIENTS IN TUNISIA: INEAS HTA REPORT AND IMPACT ON REIMBURSEMENT DECISION. Value in Health. 2020;23.
J. F. Cuello,A. Bardach,G. Gromadzyn,A. Ruiz Johnson,D. Comandé,E. Aguirre and S. Ruvinsky. Neurosurgical simulation models developed in Latin America and the Caribbean: a scoping review. Neurosurgical Review. 2023;47(1):10.1007/s10143-023-02263-2.
M. T. Caballero,A. M. Bianchi,A. Nuño,A. J. P. Ferretti,L. M. Polack,I. Remondino,M. G. Rodriguez,L. Orizzonte,F. Vallone,E. Bergel and F. P. Polack. Mortality Associated With Acute Respiratory Infections Among Children at Home. J Infect Dis. 2019;219(3):10.1093/infdis/jiy517.
Mortality Associated With Acute Respiratory Infections Among Children at Home Ver más »
F. Augustovski,N. Soto,J. Caporale,L. Gonzalez,L. Gibbons and A. Ciapponi. META-ANALYSIS OF DECISION IMPACT AND NET DECISION CHANGE IN ADJUVANT CHEMOTHERAPY ALLOCATION IN EARLY STAGE NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WITH A 21-GENE ASSAY. Value in Health. 2014;17(7):10.1016/j.jval.2014.08.2432.
L. Rey-Ares,U. Garay,S. Garcia-Marti,R. Gilardino,H. A. Cabra,A. Pichon-Riviere and F. Augustovski. MEDICAL DEVICES - FROM LICENSING TO COVERAGE: HIGHLIGHTS FROM ARGENTINA, BRAZIL, COLOMBIA, AND MEXICO. Value in Health. 2015;18(7):10.1016/j.jval.2015.09.086.
A. Hernández-Vásquez,C. Rojas-Roque,R. Vargas-Fernández and D. Rosselli. Measuring Out-of-pocket Payment, Catastrophic Health Expenditure and the Related Socioeconomic Inequality in Peru: A Comparison Between 2008 and 2017. J Prev Med Public Health. 2020;53(4):10.3961/jpmph.20.035.
F. Piñero,M. A. Thompson,F. Diaz Telli,J. Trentacoste,C. Padín,M. Mendizabal,C. Colaci,A. Gonzalez Campaña,J. Pages,S. Montal,M. Barreiro,M. Fauda,G. Podestá,J. P. Perotti and M. Silva. LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study. Ann Hepatol. 2020;19(6):10.1016/j.aohep.2020.06.007.
F. Augustovski,L. Rey-Ares,V. Irazola,M. Oppe and N. Devlin. LEAD VERSUS LAG TIME TRADE-OFF VARIANTS: DOES IT MAKE ANY DIFFERENCE? Value in Health. 2013;16(3):10.1016/j.jval.2013.03.205.
Lead versus lag time trade-off variants: does it make any difference? Ver más »
R. Vargas-Fernández,M. Chacón-Diaz,G. W. Basualdo-Meléndez,F. A. Barón-Lozada,F. J. Visconti-Lopez,D. Comandé and A. Hernández-Vásquez. Late myocardial reperfusion in ST-elevation myocardial infarction: protocol for a systematic review and meta-analysis. BMJ Open. 2022;12(9):10.1136/bmjopen-2021-059610.